ARPA-H Is Now Funding Ibogaine Trials for Opioid Use Disorder
ARPA-H's ASCENT-IBO program funds Phase 1 and 2 ibogaine trials for opioid use disorder, with patient safety up front. Solution summaries are due October 15.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
ARPA-H's ASCENT-IBO program funds Phase 1 and 2 ibogaine trials for opioid use disorder, with patient safety up front. Solution summaries are due October 15.
Read More
A new bipartisan bill would take President Trump’s psychedelic therapy order and try to make it harder to undo.
Read More
The app, called INVI Mindhealth, was created by former Navy SEAL Jonathan Wilson after he sought psychedelic treatment outside the US.
Read More
The discussion, led through Ohio’s Ibogaine Treatment Study Committee, reflects a broader shift in psychedelic policy.
Read More
Trump’s executive order on psychedelics pushed a once fringe issue into the center of health policy. The coverage shows a clear pattern.
Read More
Ibogaine's cardiac risk is real. The Stanford MISTIC protocol has reshaped the picture. A complete 2026 guide to screening, monitoring, and clinic red flags.
Read More
The new federal Right to Try pathway for ibogaine explained: who qualifies, what has to happen first, and why it won't be a prescription in 2026.
Read More
It is the most significant federal action on psychedelic medicine ever taken by a U.S. president. And Ibogaine is named twice in the text.
Read More
Trump framed the order as a response to the mental health crisis facing American veterans. Psychedelic therapy advocates are watching the move closely.
Read More
Colorado regulators are reviewing rules that could add ibogaine to the state's Natural Medicine program -- making it the first to do so.
Read More